Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;74(3):233-241.
doi: 10.1055/s-0033-1360170.

Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018

G Gross  1 , N Becker  2 , N H Brockmeyer  3 , S Esser  4 , U Freitag  5 , M Gebhardt  6 , L Gissmann  7 , P Hillemanns  8 , H Grundhewer  9 , H Ikenberg  10 , H Jessen  11 , A Kaufmann  12 , S Klug  13 , J P Klußmann  14 , A Nast  15 , D Pathirana  15 , K U Petry  16 , H Pfister  17 , U Röllinghof  18 , P Schneede  19 , A Schneider  20 , E Selka  18 , S Singer  21 , S Smola  22 , B Sporbeck  15 , M von Knebel Doeberitz  23 , P Wutzler  24
Affiliations

Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018

G Gross et al. Geburtshilfe Frauenheilkd. 2014 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The Paul Ehrlich Society for Chemotherapy (Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. [PEG]) provided the funding for the compilation of this Guideline. The Paul Ehrlich Society for Chemotherapy did not influence the contents of this Guideline in any way. GG, LG, HI, AMK, HP, KUP, PS received honoraria from the companies GlaxoSmithKline and Sanofi Pasteur MSD. PH received honoraria from several companies currently working on HPV, cervical cancer, molecular diagnostics, cytology and vaccines. AS and SS declare that they have no financial relationships with any company whose products play an important role in this Guideline (or with any company which supplies rival products).

References

    1. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Bertrams; 2008. European guidelines for quality assurance in cervical cancer screening. 2nd revised ed.
    1. Jahn I, Eberle A, Niehues C, Birn A, Horch K. Robert Koch-Institut; 2007. Gesundheitsberichterstattung des Bundes, Gebärmuttererkrankungen. Heft 37.
    1. Gross G Tyring S Keds.Sexually transmitted Infections and sexually transmitted Diseases Springer; 20119783642146626
    1. Pathirana D, Hillemanns P, Petry K U, Becker N, Brockmeyer N H, Erdmann R. et al. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia. Vaccine. 2009;27:4551–4559. - PubMed
    1. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6:204. - PubMed